MGTA - Magenta Therapeutics EPS beats by $0.02 March, 03 2021 09:34 AM Magenta Therapeutics Inc. Magenta Therapeutics (MGTA): GAAP EPS of -$0.38 beats by $0.02.Cash, cash equivalents and marketable securities of $148.8MPress Release For further details see: Magenta Therapeutics EPS beats by $0.02